FHTX - Financial Reports List - Foghorn Therapeutics Inc. - IntrinsicAlpha

Foghorn Therapeutics Inc. FHTX

Healthcare - Biotechnology - NASDAQ - US

$ 4.2

2.63 %

$ 234 M

Market Cap

-2.47

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-50.49%	19.09%	5.71%
Annual Report	FY	10-K	2024-12-31	-33.83%	11.99%	4.84%
Quarterly Report	Q3	8-K	2024-09-30	-55.33%	-33.30%	-39.64%
Quarterly Report	Q2	8-K	2024-06-30	23.02%	22.07%	24.39%
Quarterly Report	Q1	8-K	2024-03-31	-4.88%	17.95%	15.38%
Quarterly Report	Q4	8-K	2023-12-31	37.88%	29.38%	20.16%
Annual Report	FY	10-K	2023-12-31	77.63%	9.60%	7.88%
Quarterly Report	Q3	8-K	2023-09-30	163.46%	38.38%	39.56%
Quarterly Report	Q2	8-K	2023-06-30	24.70%	-7.96%	-9.81%
Quarterly Report	Q1	8-K	2023-03-31	35.43%	-17.15%	-19.83%

1